Drug Type Synthetic peptide |
Synonyms Ac-(Lys)6-alphaMSH + [1] |
Mechanism Bacterial DNA gyrase inhibitors, MC1R agonists(Melanocortin receptor 1 agonists), MC3R agonists(Melanocortin receptor 3 agonists) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC113H181N33O25S |
InChIKeyWHRVKPBBRZHWTN-ZHHKRVSMSA-N |
CAS Registry926277-68-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Modimelanotide | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | US | 01 May 2013 | |
Cardiovascular Diseases | Discovery | DK | 01 May 2013 | |
Aortic Aneurysm | Discovery | DK | 01 Oct 2010 | |
Coronary Artery Disease | Discovery | DK | 01 Oct 2010 | |
Heart Valve Diseases | Discovery | DK | 01 Oct 2010 | |
Kidney Diseases | Discovery | DK | 01 Oct 2010 | |
Acute Kidney Injury | Discovery | US | 01 Mar 2008 | |
Myocardial Infarction | Discovery | - | - | |
Reperfusion Injury | Discovery | - | - | |
Respiratory Distress Syndrome, Adult | Discovery | DK | - |